Liquid chromatography-hydride generation-atomic fluorescence spectrometry determination of arsenic species in dog plasma and its application to a pharmacokinetic study after oral administration of Realgar and Niu Huang Jie Du Pian

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 917-918, Issue , 2013, Pages 93-99

  Zhang, Yunjing ^a   Qiang, Shuping ^a   Sun, Jing ^a   Song, Min ^a   Hang, Taijun ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Arsenic speciation; Dog plasma; Liquid chromatography hydride generation atomic fluorescence spectrometry; Niu Huang Jie Du Pian; Pharmacokinetics; Realgar

Indexed keywords

ARSENIC SPECIATION; DOG PLASMA; FLUORESCENCE SPECTROMETRY; NIU HUANG JIE DU PIAN; REALGAR;

ATOMS; CHROMATOGRAPHY; FLUORESCENCE SPECTROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDRIDES; PHARMACOKINETICS;

ARSENIC;

ARSENIC; ARSENIC ACID; CACODYLIC ACID; CHINESE DRUG; METHANEARSONIC ACID; NIU HUANG JIE DU PIAN; REALGAR; UNCLASSIFIED DRUG;

ACCURACY; ANIMAL EXPERIMENT; ANION EXCHANGE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ELIMINATION; DRUG HALF LIFE; ELUTION; EXPERIMENTAL DOG; FEMALE; FLOW RATE; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY HYDRIDE GENERATION ?ATOMIC FLUORESCENCE SPECTROMETRY; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEPARATION TECHNIQUE; SINGLE DRUG DOSE; SPECTROFLUOROMETRY; TIME TO MAXIMUM PLASMA CONCENTRATION; VALIDATION PROCESS;

ADMINISTRATION, ORAL; ANIMALS; ARSENICALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOGS; DRUG STABILITY; DRUGS, CHINESE HERBAL; FEMALE; LIMIT OF DETECTION; MALE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, FLUORESCENCE; SULFIDES;

EID: 84873132419     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2012.12.029     Document Type: Article

References (40)

1. Nriagu J.O. Environmental Chemistry of Arsenic 2002, Marcel Dekker, New York. W.T. Frankenberger (Ed.).
2. Lu D.P., Wang Q. Int. J. Hematol. 2002, 76:316.
3. Meng H., Du X., Gao Y., Gao S., Yu L., Wang C. China J. Chin. Mater. Med. 1992, 17:747.
4. Chinese Pharmacopoeia Committee Pharmacopoeia of People's Republic China 2010, vol. 1. China Medical Science and Technology Press, Beijing, p. 566.
5. Liu J., Lu Y., Wu Q., Goyer R.A., Waalkes M.P. J. Pharmacol. Exp. Ther. 2008, 326:363.
6. Deng J.F., Wu M.L., Tsai W.J., Ger J., Yang C.C. Toxicol. Lett. 1998, 95:73.
7. Tong Y., Zhang L., Yang J., Yang L., Wang Y., Qu J., Zhang C. Chin. J. Chin. Mater. Med. 2010, 35:1342.
8. Tang Y., Ou W., Wang N., Liu Q. Tradit. Chin. Drug Res. Clin. Pharmacol. 2008, 19:372.
9. Tang Y., Wang N., Mi S., Ou W., Ye S. Pharmacol. Clin. Chin. Mater. Med. 2009, 25:39.
10. Lu D.P., Qiu J.Y., Jiang B., Wang Q., Liu K.Y., Liu Y.R., Chen S.S. Blood 2002, 99:3136.
11. Fox E., Razzouk B.I., Widemann B.C., Xiao S., O'Brien M., Goodspeed W., Reaman G.H., Blaney S.M., Murgo A.J., Balis F.M., Adamson P.C. Blood 2008, 111:566.
12. Fukai Y., Hirata M., Ueno M., Ichikawa N., Kobayashi H., Saitoh H., Sakurai T., Kinoshita K., Kaise T., Ohta S. Biol. Pharm. Bull. 2006, 29:1022.
13. Sweeney C.J., Takimoto C., Wood L., Porter J.M., Tracewell W.G., Darwish M., D'Andrea D.M., Remick S.C. Cancer Chemother. Pharmacol. 2010, 66:345.
14. Tie B., Qiao W., Ma Z., Wang W. Chin. J. Chin. Mater. Med. 1992, 17:285.
15. Chen B.W., Hua N., Lu M.L., Le X.C. Prog. Chem. 2009, 21:474.
16. Koch I., Sylvester S., Lai V.W.M., Owen A., Reimer K.J., Cullen W.R. Toxicol. Appl. Pharmacol. 2007, 222:357.
17. Tang Y., Wang N. J. Mod. Food Pharm. 2006, 3:769.
18. Xu Z., Yu S., Huang K. Chin. J. Biomed. Pharm. 2009, 30:121.
19. Sanchez-Rodas D., Corns W.T., Chen B., Stockwell P.B. J. Anal. Atom. Spectrom. 2010, 25:933.
20. Guideline on bioanalytical method validation, EMEA/CHMP/EWP/192217/2009, Committee for Medicinal Products for Human Use (CHMP), European Medicines Agency, 7 Westferry Circus, Canary Wharf, London E14 4HB, United Kingdom, 2011. (last accessed 15.12.12). http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf.
21. Hsieh Y.J., Jiang S.J. J. Agric. Food Chem. 2012, 60:2083.
22. Scheer J., Findenig S., Goessler W., Francesconi K.A., Howard B., Umans J.G., Pollak J., Tellez-Plaza M., Silbergeld E.K., Guallar E., Navas-Acien A. Anal. Methods 2012, 4:406.
23. Radke B., Jewell L., NamieŚnik J. Crit. Rev. Anal. Chem. 2012, 42:162.
24. Zhang X., Cornelis R., De Kimpe J., Mees L. Anal. Chim. Acta 1996, 319:177.
25. Mandal B.K., Ogra Y., Anzai K., Suzuki K.T. Toxicol. Appl. Pharmacol. 2004, 198:307.
26. Guerin T., Astruc A., Astruc M. Talanta 1999, 50:1.
27. Demesmay C., Olle M., Porthault M. Fresenius J. Anal. Chem. 1994, 348:205.
28. Monasterio R.P., Londonio J.A., Farias S.S., Smichowski P., Wuilloud R.G. J. Agric. Food Chem. 2011, 59:3566.
29. Almeida A.M., Castel-Branco M.M., Falcão A.C. J. Chromatogr. B 2002, 774:215.
30. Schulz M., Schmoldt A. Pharmazie - Int. J. Pharm. Sci. 2003, 58:447.
31. Vahter M. Toxicology 2002, 181-182:211.
32. Feldmann J., Lai V.W., Cullen W.R., Ma M., Lu X., Le X.C. Clin. Chem. 1999, 45:1988.
33. Buchet J.P., Lauwerys R., Roels H. Int. Arch. Occup. Environ. Health 1981, 48:71.
34. Kaise T., Yamauchi H., Horiguchi Y., Tani T., Watanabe S., Hirayama T., Fukui S. Appl. Organomet. Chem. 1989, 3:273.
35. Chinese Pharmacopoeia Committee Pharmacopoeia of People's Republic China 2010, vol. 1. China Medical Science and Technology Press, Beijing, (Appendix II D).
36. Suzuki K.T., Mandal B.K., Ogra Y. Talanta 2002, 58:111.
37. Wang K., Yu S., Zhang T. Biological Chemistry of Arsenic, Antimony and Bismuth 2010, 113-133. John Wiley & Sons, Ltd., Berlin/Heidelberg. H. Sun (Ed.).
38. Bai B., Li X., Yang K., Song Y., Sun Y., Ding G. Chin. Pharm. 2010, 13:626.
39. Wang X., Xi R., Yang X., Yang X. Chin. J. New Drugs 2007, 16:1758.
40. Wu X., Sun D., Zhuang Z., Wang X., Gong H., Hong J., Lee F.S.C. Anal. Chim. Acta 2002, 453:311.